| TAA-T | Autologous tumor-associated antigen-specific cytotoxic T lymphocytes |
| TAC | TAC regimen |
| TACE | Transarterial chemoembolization |
| TAE | Transarterial embolization |
| TAGM | Tris-acryl gelatin microspheres |
| TA-HPV | Human papillomavirus tumor antigen vaccine |
| T-allo10 | Alloantigen-specific allogeneic type 1 regulatory T cells T-allo10 |
| TAM | Transient abnormal myelopoiesis; Transient leukemia; Transient myeloproliferative disorder; Tamoxifen citrate |
| t-AML | Therapy-related acute myeloid leukemia |
| TAU | Uridine triacetate |
| TAX | Paclitaxel |
| TB | Tuberculosis; Tributyrin |
| TBC | Tubercidin |
| TBI | Total-body irradiation |
| TBZ | Thiabendazole |
| Tc 99m LL2 | Technetium Tc 99m epratuzumab |
| Tc 99m mebrofenin | Technetium Tc 99m mebrofenin |
| Tc 99m-labeled MAA | Technetium Tc 99m-labeled macroaggregated albumin |
| Tc-99m hydroxydiphosphonate | Technetium Tc 99m hydroxydiphosphonate |
| Tc-99m MIBI | Technetium Tc-99m sestamibi |
| Tc-99m SC | Technetium Tc 99m-sulfur colloid |
| Tc-99m-DTPA | Technetium Tc 99m DTPA |
| TCAR | Tiazofurin |
| TCE | Tethered capsule endoscope |
| TCGA | The Cancer Genome Atlas |
| TCM | Oriental medicine; Traditional Chinese Medicine |
| TCN-P | Triciribine phosphate |
| TCR | T-cell receptor |
| TdCyd | 4-thio-2-deoxycytidine |
| TDF | Tenofovir disoproxil fumarate |
| T-DM1 | Ado-trastuzumab emtansine; Kadcyla |
| TDR | Third-degree relative |
| TDZ | Tinidazole |
| TEL540-548 | Telomerase: 540-548 peptide vaccine |
| TENS | Transcutaneous electrical nerve stimulation |
| TESA | Testicular sperm aspiration |
| TESE | Testicular sperm extraction |
| Tet p | Tetanus peptide melanoma vaccine |
| TET TOX PEP VAC | Tetanus toxoid helper peptide |
| TETA | Trientine hydrochloride |
| TetMYB | TetMYB vaccine |
| TETTOX | Tetanus toxoid |
| tetwtCEA DNA | CEA/tetanus toxoid T helper epitope fusion protein-expressing DNA plasmid vaccine |
| TFF | Trofosfamide |
| TGCT | Tenosynovial giant cell tumor |
| TGU | Anaxirone |
| THC | Dronabinol |
| therapeutic ADH | Argipressin |
| therapeutic allogeneic CTLs | Therapeutic allogeneic cytotoxic T lymphocytes |
| therapeutic Ang-(1-7) | Therapeutic angiotensin-(1-7) |
| therapeutic LH | Recombinant luteinizing hormone |
| Therapeutic T3 | Therapeutic triiodothyronine |
| THP-DOX | Pirarubicin |
| THU | Tetrahydrouridine |
| TIL | Tumor-infiltrating lymphocyte |
| TL | Testolactone |
| TLF | Talactoferrin alfa |
| TLK286 | Telcyta |
| TM | Transcendental Meditation |
| Tma | Thrombomodulin alfa |
| TMB | Tumor mutational burden |
| TMCA | Trimethylcolchicinic acid |
| TMD | Transient abnormal myelopoiesis; Transient leukemia; Transient myeloproliferative disorder |
| TMNDGA | Terameprocol |
| TMZ | Temozolomide |
| TNBC | ER-negative PR-negative HER2/neu-negative breast cancer; Triple-negative breast cancer |
| TNF | Recombinant tumor necrosis factor family protein |
| TNX-650 | Lebrikizumab |
| topical TCA | Topical trichloroacetic acid |
| TORS | Transoral robotic surgery |
| TP-38 | TGFa-PE38 immunotoxin |
| TPA | Tetradecanoylphorbol acetate; Tissue plasminogen activator |
| TPF | Docetaxel-cisplatin-fluorouracil; Taxotere-Platinol-fluorouracil; TPF regimen |
| TPN | Total parenteral nutrition |
| TPO | Thrombopoietin |
| TRAIL | TNF-related apoptosis-inducing ligand; Tumor necrosis factor-related apoptosis-inducing ligand |
| TRAIL-R1 | Death receptor 4; TRAIL receptor 1; Tumor necrosis factor receptor superfamily member 10A |
| TRAIL-R2 | Death receptor 5; TRAIL receptor 2; Tumor necrosis factor receptor superfamily member 10B |
| TRF | Tocotrienol-rich fraction |
| TRM-1 mAb | Mapatumumab |
| TRP-1 | Tyrosinase-related protein-1 |
| TRP-2 | Recombinant tyrosinase-related protein-2 |
| TRPV6 | Transient receptor potential cation channel, subfamily V, member 6 |
| TRS | Traumeel S |
| TRUS | Endorectal ultrasound; Transrectal ultrasound |
| TSC | Trans sodium crocetinate |
| TSH | Thyroid-stimulating hormone |
| TSH-alpha | Recombinant thyrotropin alfa |
| TSNA | Tobacco-specific nitrosamine |
| TSPA | Thiotepa |
| TTFD | Fursultiamine |
| tTF-NGR | Truncated tissue factor/NGR peptide |
| TTI-237 | TTI 237 |
| TTMB | Transperineal template-guided prostate mapping biopsy |
| TTP | Time to progression |
| TTX | Tetrodotoxin |
| TUEVAP | Transurethral electroevaporation of the prostate; Transurethral electrovaporization of the prostate |
| TUIP | Transurethral incision of the prostate |
| TUMT | Transurethral microwave thermotherapy |
| TUNA | Transurethral needle ablation; Transurethral radiofrequency ablation |
| TUR | Transurethral resection |
| TURP | Transurethral resection of the prostate |
| TUVP | Transurethral electroevaporation of the prostate; Transurethral electrovaporization of the prostate |
| T-VEC | Talimogene laherparepvec; Imlygic |
| TVS | Transvaginal sonography; Transvaginal ultrasound |
| TYRP | Tyrosinase peptide |
| TZT-1027 | Soblidotin |